Our latest research, published in , explores the use of inhaled mRNA nanoparticles to target lung cancer cells and inflammatory macrophages. This breakthrough opens new avenues for mRNA-based therapies in treating lung diseases.
Recent Publication: Pioneering mRNA Technology for Lung Cancer Therapy
Comments